Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX1000 vs Rocuronium for Neuromuscular Blockade in Elective Surgery
NCT05687253Phase 2Completed
- Sponsor
- Baudax Bio
- Start
- Oct 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BX-1000 in neuromuscular blockade (NMB), sponsored by Baudax Bio. Started Oct 2022; status: completed.
02
Drugs
BX-1000
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05687253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687253.